Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734006 · ClinicalTrials.gov registry record
Cortico-cortical Connectivity During Midazolam Sedation in Humans; a TMS/EEG Study
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 20
- Enrollment target
NCT00734006: Completed study, sponsored by University of Wisconsin, Madison.
NCT00734006 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00734006 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The aim of the proposed research is to measure the effect of drug-induced sedation on the functional connectivity between brain regions as indicated by EEG signal transmission within the human brain. The results of this study will help to identify the neurophysiological correlates of changes in conscious experience that occur during drug-induced sedation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-03 |
What the finished NCT00734006 record still lists
NCT00734006 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00734006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00734006 about?
NCT00734006 is a clinical study titled "Cortico-cortical Connectivity During Midazolam Sedation in Humans; a TMS/EEG Study". The aim of the proposed research is to measure the effect of drug-induced sedation on the functional connectivity between brain regions as indicated by EEG signal transmission within the human brain. The results of this study will help to identify the neurophysiological correlates of changes in cons...
What is the current status of trial NCT00734006?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-07. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT00734006?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia